SR6-23926-93943
3 vaccinations
4 coded responses
27 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 220 / VA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-18
- 2020-12-19
- 2020-12-21
- 2020-12-22
- 2020-12-30
-
2021-01-03
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-07
-
2021-01-11
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Noticed lymphadenopathy shortly after second injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-24
- 2021-02-02
- 2021-02-14
- 2021-04-06
-
2021-07-04
Survey response — 6 months, dose 2MedDRA: Cough — Feeling: GoodFree text: Cough for over a monthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-05
- 2021-11-10
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Delivery — Feeling: GoodFree text: Had a baby 12/16/21MedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-03 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Free text
Release 1 — day 7, dose 2
Systemic reaction (other): Noticed lymphadenopathy shortly after second injection
Release 9 — 6 months, dose 2
Symptoms: Cough for over a month
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lymphadenopathy
Release 10 — 3 months, dose 3
Symptoms: Had a baby 12/16/21
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Delivery | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release